drug development | Being Patient

Alzheon’s Pill For Alzheimer’s Recruits for Clinical Trials

By Simon Spichak, MSc | October 12th, 2022

Alzheon’s new Alzheimer’s ALZ-801 drug is finishing up recruiting for Phase 3 clinical trials. If the trial proves successful, it may become the first…

Canine dementia Dementia dogs drug development Phil's Journal

Phil’s Journal: Dog Dementia, or Bea’s Story

By Phil Gutis | September 29th, 2022

Reporter Phil Gutis is living with Alzheimer’s. So is his dog, Bea. One day, the same approach to treatment might help them both. Sometimes…

aduhelm drug, aducanumab, alzheimer's treatment - fda aduhelm investigation

aducanumab aduhelm Alzheimer's drug development

FDA Head Calls for Investigation Into Controversial Aduhelm Approval

By Simon Spichak | July 12th, 2021

Image: Aduhelm, Biogen/AP. The head of the FDA, Dr. Janet Woodcock, calls for investigation into the agency’s own controversial approval of Biogen’s Aduhelm, the…

Latest for #drug development